SPON1 and cancer: Recently, we have demonstrated that F-spondin, encoded by SPON1, participates in the signaling pathway by which 2ME exerts its apoptotic activity in cancer cells so that this 2ME-target gene is a good marker for the biological effects of this estrogen metabolite [7,8].